EXHIBIT 99.1
October 7, 2022
AD Office of Life Sciences
Securities and Exchange Commission
100 F St., NE, Mail Stop 4561
Washington, DC 20549-4561
To the Assistant Director Office:
We have received a copy of, and are in agreement with, the statements being made by GelStat Corp. in Item 4 of its Form 1-U dated October 5, 2022, captioned “Changes in Issuer’s Certifying Accountant”.
Very truly yours, | |
56 Rockford Road, Wilmington, DE 19806-1004 | Phone: 302-652-4783
ciroadamscpa.com